Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Genetic analysis of invasive carcinoma arising in intraductal oncocytic papillary neoplasm of the pancreas.

Patel SA, Adams R, Goldstein M, Moskaluk CA.

Am J Surg Pathol. 2002 Aug;26(8):1071-7.

PMID:
12170096
2.

Intraductal oncocytic papillary neoplasms of the pancreas.

Adsay NV, Adair CF, Heffess CS, Klimstra DS.

Am J Surg Pathol. 1996 Aug;20(8):980-94.

PMID:
8712298
3.

Intraductal oncocytic papillary neoplasm of the bile duct: clinicopathologic and immunohistochemical characteristics of 6 cases.

Tanaka M, Fukushima N, Noda N, Shibahara J, Kokudo N, Fukayama M.

Hum Pathol. 2009 Nov;40(11):1543-52. doi: 10.1016/j.humpath.2009.03.014. Epub 2009 Jun 21.

PMID:
19540556
4.

Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract.

Abraham SC, Lee JH, Hruban RH, Argani P, Furth EE, Wu TT.

Hum Pathol. 2003 Sep;34(9):902-10.

PMID:
14562286
6.

Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.

Sasaki S, Yamamoto H, Kaneto H, Ozeki I, Adachi Y, Takagi H, Matsumoto T, Itoh H, Nagakawa T, Miyakawa H, Muraoka S, Fujinaga A, Suga T, Satoh M, Itoh F, Endo T, Imai K.

Oncol Rep. 2003 Jan-Feb;10(1):21-5.

PMID:
12469138
7.

Intraductal oncocytic papillary neoplasm of the pancreas: report of a case requiring completion pancreatectomy.

Wohlauer MV, McManus M, Fukami N, Gajdos C.

JOP. 2013 Jan 10;14(1):77-80. doi: 10.6092/1590-8577/1259.

8.
9.

Intraductal oncocytic papillary neoplasm of the pancreas: a radio-pathological case study.

Fischer MA, Donati O, Heinrich S, Weber A, Hany TF, Soldini D, Alkadhi H, Marincek B, Scheffel H.

JOP. 2010 Jan 8;11(1):49-54.

10.

Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden).

de vos tot Nederveen Cappel WH, Offerhaus GJ, van Puijenbroek M, Caspers E, Gruis NA, De Snoo FA, Lamers CB, Griffioen G, Bergman W, Vasen HF, Morreau H.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3598-605.

11.
12.

Biologically different subgroups of invasive ductal carcinoma of the pancreas: Dpc4 status according to the ratio of intraductal carcinoma components.

Takahashi H, Oda T, Hasebe T, Aoyagi Y, Kinoshita T, Konishi M, Nakagohri T, Inoue K, Takahashi S, Kawahira H, Monden M, Ochiai A.

Clin Cancer Res. 2004 Jun 1;10(11):3772-9.

13.

Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms.

Basturk O, Zamboni G, Klimstra DS, Capelli P, Andea A, Kamel NS, Adsay NV.

Am J Surg Pathol. 2007 Mar;31(3):363-70.

PMID:
17325477
14.

Immunohistochemical study of genetic alterations in intraductal and invasive ductal tumors of the pancreas.

Islam HK, Fujioka Y, Tomidokoro T, Sugiura H, Takahashi T, Kondo S, Katoh H.

Hepatogastroenterology. 2001 May-Jun;48(39):879-83.

PMID:
11462947
15.

P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas.

Mueller J, Gansauge S, Mattfeldt T.

Hepatogastroenterology. 2003 Mar-Apr;50(50):541-4.

PMID:
12749268
16.

Genetic alterations in adenoma-carcinoma sequencing of intraductal papillary-mucinous neoplasm of the pancreas.

Nakata B, Yashiro M, Nishioka N, Aya M, Yamada S, Takenaka C, Ohira M, Ishikawa T, Nishino H, Wakasa K, Hirakawa K.

Int J Oncol. 2002 Nov;21(5):1067-72.

PMID:
12370756
17.

Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.

Adsay NV, Basturk O, Cheng JD, Andea AA.

Semin Radiat Oncol. 2005 Oct;15(4):254-64. Review.

PMID:
16183479
18.

Ki-ras oncogene activation in preinvasive pancreatic cancer.

Lemoine NR, Jain S, Hughes CM, Staddon SL, Maillet B, Hall PA, Klöppel G.

Gastroenterology. 1992 Jan;102(1):230-6.

PMID:
1309358
19.

MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).

Ueda M, Miura Y, Kunihiro O, Ishikawa T, Ichikawa Y, Endo I, Sekido H, Togo S, Shimada H.

Hepatogastroenterology. 2005 Mar-Apr;52(62):398-403.

PMID:
15816444
20.

Supplemental Content

Support Center